We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





Protein Biomarkers Could Predict If COVID-19 Patients Can Become Severely Ill

By HospiMedica International staff writers
Posted on 08 Jun 2020
Print article
Image: Illustration of a 2019-novel coronavirus (nCoV) virion (Photo courtesy of Alissa Eckert, MS/CDC).
Image: Illustration of a 2019-novel coronavirus (nCoV) virion (Photo courtesy of Alissa Eckert, MS/CDC).
Researchers have identified 27 protein biomarkers that could be used to predict whether a patient with COVID-19 is likely to become severely ill with the disease.

In their study, researchers at the Francis Crick Institute (London, UK) and Charité – Universitätsmedizin Berlin (Berlin, Germany) found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending upon the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.

The researchers refined an analysis method called mass spectrometry to rapidly test for the presence and quantity of various proteins in the blood plasma. This platform was developed at the Francis Crick Institute and applied to analyze serum of 31 COVID-19 patients at the Berlin University hospital Charité. Their results were further validated in 17 patients with COVID-19 at the same hospital and in 15 healthy people. Three of the key proteins identified by the researchers were associated with interleukin IL-6, a protein which causes inflammation, a known marker for severe symptoms. The researchers hope that their findings will lead to the development of simple routine tests to check for the levels for one or some of these proteins in patients with COVID-19. The results of such tests could be used to support doctors in deciding what treatment to give.

“A test to help doctors predict whether a COVID-19 patient is likely to become critical or not would be invaluable. It will help them make decisions about how to best manage the disease for each patient as well as identify those most at risk,” said Christoph Messner, one of the lead authors and postdoc in the Molecular Biology of Metabolism Laboratory at the Crick. “We hope the biomarkers we’ve identified will lead to the development of these vitally needed tests.”

“The robust method we’ve used in this study is a valuable and powerful tool to predict disease progression and also find potential targets for treatments. Our approach could also be easily applied to other diseases, now and in the future, to understand more about their effects on the body,” said Markus Ralser, paper author and group leader at the Crick and Charité.

Related Links:
Francis Crick Institute
Charité – Universitätsmedizin Berlin


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Diagnosis Display System
C1216W
New
Fetal and Maternal Monitor
F9 Series

Print article

Channels

Critical Care

view channel
Image: The UbiqVue 2A Multiparameter System is based around a wearable ciosensor with chest-based SpO2 (Photo courtesy of LifeSignals)

Multiparameter System Featuring Wearable Biosensor Enables Continuous, Near Real-Time Patient Monitoring

A novel cloud-based system featuring a wearable biosensor with chest-based SpO2 monitoring enables continuous patient monitoring across both hospital and out-of-hospital care settings. The UbiqVue 2A... Read more

Surgical Techniques

view channel
Image: The Toumai system has successfully completed over 200 human robotic telesurgery cases globally (Photo courtesy of MicroPort Medbot)

Surgical Robot System with Telesurgery Capability to Revolutionize Healthcare Delivery

Robotic telesurgery, or remote surgery, is a technique where a surgeon operates on a patient from a distance using a robot and telecommunication networks. This approach allows surgeons to conduct procedures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.